hibitory concentration of boric acid indicate that boric acid works at a pH similar to that of the untreated vaginal tract, and, therefore, the action may not be simply due to an increase in acidity. 6, 7 
PHARMACOKINETICS
Boric acid is rapidly and completely absorbed following oral ingestion and is well absorbed through denuded and abraded skin in solution or as a dry powder. 8 Absorption has been reported to be negligible through intact skin in the presence of alkaline salts. 9 Once absorbed, boric acid is widely distributed throughout body water and accumulates in the brain, liver, and kidneys. 8 16 Other reports of vaginally administered boric acid in more than 2,000 patients reveal an absence of toxicity. 7 The risk of systemic toxicity depends on the concentration used, route of administration, age of the patient, skin condition, and duration of exposure. The fatal adult dose is thought to be about 20 grams or 0.1-0.5 mg/kg taken orally. 8 Boric acid poisoning affects multiple organ systems including the gastrointestinal tract, central nervous system (CNS), skin, liver, and kidneys. Vomiting, diarrhea, and abdominal pain are the most common symptoms. Excitement of the CNS followed by malaise, lethargy, headache, seizures, coma, and hyperpyrexia also occurs. Additionally, an erythematous, vesicular, or papular rash with desquamatization, referred to as boiled lobster syndrome, may be observed. The kidneys are probably the most seriously affected of all the organs involved, resulting in renal tubular necrosis, anuria, and albuminuria. Death resulting from cardiovascular collapse, shock, or respiratory failure may occur within 3-5 days of acute poisoning. 8, 9 The risk of systemic toxicity due to vaginal administration of boric acid is minimal. 7 Symptoms of chronic intoxication include anorexia, gastrointestinal disturbances, weakness, confusion, dermatitis, menstrual disorders, anemia, seizures, and alopecia. No drug-drug interactions have been reported involving boric acid. 8, 9 SPECTRUM OF ACTIVITY Early reports of in vitro testing indicate that boric acid has some activity against staphylococci and streptococci, although the suggested action is primarily bacteriostatic and slow-acting. 9 The use of boric acid in the preservation of urine samples has also been described. 17 
